CACNA1B and colorectal cancer: Another study on the cytotoxicity of HT29-D4 paclitaxel human colorectal cancer cells has demonstrated that undifferentiated and differentiated cancer cells differ in their sensitivity to paclitaxel, owing to altered βIII-microtubule protein expression.